patients, but it is uncertain whether oxygen supplementation beyond normoxia is safe and actually improves DO 2 .
Hyperoxia may increase ICU mortality [5] [6] [7] and myocardial infarct size. 8 On the other hand, moderate hyperoxia may alleviate organ dysfunction after cardiac arrest. 9 In mechanically ventilated ICU patients, the (retrospective) relation between the degree of hyperoxia and mortality is U-shaped, with a nadir around 15-20 kPa. 10 Potential adverse effects of hyperoxia may occur via microvascular constriction 11, 12 and a reduction in cardiac output. [13] [14] [15] [16] However, findings regarding such effects are ambiguous. 17, 18 The reduced perfusion and cardiac output may lead to a net loss of DO 2 that had been found in some, [19] [20] [21] but not all studies.
22-24
The evidence for hyperoxia causing microvascular constriction mostly comes from animal studies. In humans, the effects of hyperoxia on the microvasculature consists of indirect measures, such as an increase in SVR 15, [25] [26] [27] or a reduction in peripheral blood flow. [28] [29] [30] [31] Recently, a direct effect of hyperoxia on the sublingual microcirculation was shown. 32 In this study, a marked decrease in PVD (−30%) was observed, when 10 healthy volunteers breathed pure oxygen for 30 minutes. However, as with most studies on hyperoxia, only 2 inspired oxygen concentrations were studied; air (21% O 2 ) and pure oxygen (100%). Although this comparison creates the highest contrast, its clinical relevancy is limited. An F I O 2 of 1.0 is rarely used in daily practice to avoid the direct toxicity of pure oxygen to the lungs. Second, the P a O 2 s that arise from breathing pure oxygen by healthy volunteers is not comparable to the ones in patients with existing lung pathology.
As a result, the relation between hemodynamic effects of oxygen and P a O 2 at clinically relevant doses remains unknown.
Only a few groups investigated the dose-response effect of oxygen on the cardiovascular system 15, 26 and none directly visualized the microcirculation. It is therefore currently unknown at which P a O 2 the microcirculatory effects of hyperoxia start to occur and what the nature of the dose-response effect is.
The aim of this study was to determine the dose-response relationship between a stepwise increase in P a O 2 and its associated changes in DO 2 and sublingual microcirculatory perfusion.
| MATERIALS AND METHODS

| Study design and ethical approval
Single-blind, cross-over physiological study with healthy volunteers performed at the ICU of the VU University Medical Centre (Amsterdam, the Netherlands). The study protocol was approved by the Dutch Central Committee on Research Involving Human Subjects (NL5816602916) and conformed to the standards set by the Declaration of Helsinki.
| Subjects
Volunteers were recruited through social media and were eligible for participation if they were 18 years or older and had no medical history of pulmonary or cardiovascular disease. A modified Allen test was performed to assess arterial competency, and subjects without a patent ulnar artery were not included. Subjects were included after written informed consent was obtained.
| Protocol
| Preparation
Subjects lay in a semirecumbent position in a temperature-controlled room at the ICU. After application of a local anesthetic (lidocaine), the radial artery was cannulated for blood sampling and blood pressure measurements. A finger cuff was placed on the index or middle finger for continuous measurement of hemodynamic parameters by the volumeclamp method, according to the manufacturer's instructions (Nexfin ® , BMEYE, Amsterdam, the Netherlands). Finally, subjects were fitted with a noninvasive ventilation mask coupled to a SERVO-I mechanical ventilator (Maquet, Rastatt, Germany). The ventilator was set to provide zero continuous positive airway pressure or pressure support. When the subjects were accustomed to the setup (~15 minutes after radial artery cannulation), the intervention and measurements were started.
| Intervention
The 
| Measurements
At the end of each period, the NIV mask was removed and the sublingual microcirculation was visualized immediately (within one minute)
with SDF (MicroVision Medical BV, Amsterdam, the Netherlands).
In SDF imaging, green light is emitted from the device which is then absorbed by the Hb present in erythrocytes. SDF therefore relies on the presence of Hb to visualize blood vessels. Three to 5 sites were recorded and analyzed in accordance with the latest quality recommendations. 33 After acquisition, the video files were stored for Although not regularly reported, we also calculated the number of intermittent perfused vessels (IFD) in a similar fashion. All recordings and analyses were carried out by the same operator (BS). All data reported pertain to small vessels with a diameter of 20 μm or less.
Heart rate, CI, SVI, and SVRI were measured continuously during the entire experiment. MAP was measured via the arterial line.
The average of the last 2 minutes of each exposure was used for statistics.
Blood gas and metabolite parameters were measured on-site with an ABL800 FLEX analyzer (Radiometer, Copenhagen, Denmark).
| Calculations
Systemic DO 2 index was calculated by multiplying CI with the C a O 2 .
For the latter, the following formula was used;
| Statistics
All 
| RESULTS
| Volunteers and measurements
Baseline characteristics of the 15 included volunteers are listed in Table 1 . All participants gave written informed consent and completed the entire protocol without adverse events. On average, the duration of the study was 95 minutes (SD 8). In one subject, continuous meas- 
| Intervention/Respiration/Blood gas
The obtained P a O 2 s during the 5 periods were 14 kPa (SD 1.3), 20 kPa (SD 1.8), 39 kPa (SD 3.0), 57 kPa (SD 4.9), and 73 kPa (SD 4.1). The F I O 2 s required to reach these oxygen tensions was 21% (SD 0), 29 (SD 2), 55 (SD 3), 80 (SD 5), and 100 (SD 0), respectively. Blood gas analysis revealed no changes in P a CO 2 or pH. Glucose and lactate decreased slightly during the study period but remained within normal ranges.
| Systemic hemodynamic effects
The absolute values for all systemic hemodynamics at each study period are reported in Table 2 . Hyperoxia resulted in a linear decrease in CI ( Figure 1 , P slope = .009). The largest decrease occurred while breathing pure oxygen (max −10%, SD 10). This decrease was due to a similar reduction in HR (max −10%, SD 7, P slope = .009), as stroke volume remained unchanged (P slope = .75). MAP was not affected by hyperoxia (P slope = .68). SVRI increased slightly over the entire P a O 2 range ( Figure 2 ) to a maximum of +7% (SD 8, P slope = .009). On visual inspection, the SVRI data fitted a second order polynomial equation better than a linear one, although the Sy.x statistics were identical (8.1).
| Oxygen delivery
The oxygen content of arterial blood increased linearly to a maximum of +8% (SD 3, P slope < .0001) when breathing pure oxygen ( Table 2 , Figure 1 ). Systemic DO 2 index remained unaltered (P slope = .83). Figure 3A . When breathing oxygen, the number of perfused vessels was reduced and blood flow became stagnant or intermittent, visible as "dotted" vessels in Figure 3B .
| Sublingual microcirculation
| DISCUSSION
The main finding of this study is that in healthy volunteers, supplemental oxygen does not alter DO 2 , while sublingual PVD decreased in a sigmoidal fashion as P a O 2 was increased stepwise from 14 up
T A B L E 1 Baseline characteristics
Variable Participants
Number 15
Gender (male/female) 7/8
Age (y) 30 (9) Height (cm) 175 (9) Weight (kg) 71 (11) BSA (m to 73 kPa. Hyperoxia decreased CI, by a reduction in HR rather than stroke volume, and increased SVRI. MAP was unchanged.
In this healthy volunteer population, the increase in C a O 2 caused
by an increase in P a O 2 was negated by a simultaneous reduction in CI.
Two previous studies in healthy volunteers on hemodynamic effects of oxygen showed a slight decrease in DO 2, 24,34 while another showed no effect. 35 In patients, a similar heterogeneity has been seen as DO 2 was reduced in 2 studies, 22,23 but remained unaltered in 2 others.
17,19
An important conclusion from our study is that, in nonhypoxemic individuals, an intended increase in DO 2 is not achieved by any level of normobaric oxygen supplementation.
We found a significant reduction in sublingual PVD simultaneous to a stepwise increase in P a O 2 in this group of healthy individuals. Changes in the sublingual microcirculation in response to an increase in the F I O 2 to 1.0 also occur in patients after coronary artery bypass surgery and in a cohort of mixed ICU patients (postcardiac arrest, neurological defects, polytrauma, sepsis). 18, 36 Critical illness is associated with (regional) disturbances in microcirculatory perfusion. 37 It is possible that systemic oxygen-induced changes in blood flow further impair regional perfusion and cause a mismatch between DO 2 and demand. 38 For example, in an animal model for severe coronary artery stenosis, hyperoxia was found to exacerbate myocardial ischemia due to coronary vasoconstriction. 39 In our study, we found no evidence for cellular hypoxia (as indicated by lactate), but this may be different in the critically ill with pre-existing perfusion defects. Either way, in terms of oxygenation, there appears to be no clear advantage to supraphysiological oxygen tensions; in a best-case scenario, there is no effect on DO 2 , and in a worst-case, an unintended reduction.
This is the first study in which dose-dependent effects of oxygen on the sublingual microcirculation are described. The relation between P a O 2 and PVD could be fitted with both a linear and a sigmoidal curve. Both models performed similarly based on the standard deviation of errors in regression. However, the graphical presentation of the data pleads for a sigmoidal relation between P a O 2 and PVD.
Also, a nonlinear relation is corroborated by observations carried out Hemodynamics (n = 14)
HR (bpm) 64 (7) 62 (8) 60 (8) 58 (7) 58 (7) .009
56 (7) 57 (7) 58 (8) 58 (7) 57 (8 Data are presented as mean (SD). VD, vessel density; PVD, perfused vessel density; PPV, proportion of perfused vessels; MFI, microvascular flow index; IFD, intermittent flow density; HR, heart rate; MAP, mean arterial pressure; SVI, stroke volume index; CI, cardiac index; SVRI, systemic vascular resistance index; C a O 2 , arterial oxygen content; DO 2 , oxygen delivery. *P-values for slope.
in hamsters, 40, 41 rats, 42 and rabbits. 43 In another study with healthy volunteers, a reduction in PVD of approximately 30% 32 was found, which is much larger than the effect (of ~15%) found in our study.
Discrepancies may be explained by differences in study design: prolonged exposure to hyperoxia (30 vs 10 minutes) and an acute exposure to pure oxygen (vs the gradual increase in our study). The SVR, which is an indicator of vasoconstriction, shows a sharp increase after 5-10 minutes and then further increases by a small amount over the course of an hour in healthy volunteers 25, 44 and postoperative critically ill patients. 17 SVR does not show a larger increase when volunteers are acutely 16, 24, 26, 27, [45] [46] [47] [48] or chronically exposed to oxygen. 15, 35, [49] [50] [51] The difference in effect size may therefore be partially explained by the exposure time.
The exact mechanism behind the constrictive effect of high arterial oxygen tensions is currently unclear. Reactive oxygen species (ROS) are one possible candidate, considering that in vitro, as PO 2 increases, so does the production of superoxide. 52 Superoxide reacts heavily with the vasodilator nitric oxide, reducing its bioavailability and thereby causing vasoconstriction. This has been shown directly in porcine coronary arteries 53 and indirectly in human studies; where the scavenging of ROS by infusion of high levels of vitamin C reduced or prevented hyperoxic constriction. 11, 12, 54 However, the involvement of ROS is not found uniformly. 25, 55 Intravital studies in hamsters, rat, and mice suggest that other pathways may be involved, including inactivation of calcium 56, 57 and potassium channels 57, 58 or the alteration of the metabolism of arachidonic acid. 59, 60 For instance, high PO 2 was found to decrease the activity of the enzyme cyclooxygenase, reducing the formation of dilating prostaglandins from arachidonic acid. [61] [62] [63] Conversely, the production of the vasoconstrictor 20-HETE from arachidonic acid by the CYP-450 pathway was shown to be increased by hyperoxia. [64] [65] [66] These observations are however not mutually exclusive, different mechanisms of hyperoxic vasoconstriction may be present depending on the vascular bed and/or species under investigation.
Our study shows a small imbalance between the reduction in PVD and SVRI. At higher P a O 2 s (>57 kPa), the fractional decrease in PVD was larger than the increase in SVRI. Based on the data from our study, we can only speculate why this is the case. One possible explanation is heterogeneity between microvascular beds: Capillary recruitment in the sublingual area may decrease, while recruitment in other areas/organs remains unaltered or increases. As a result, the effect of increasing P a O 2 on the PVD in the sublingual microcirculation may be larger than on SVR. In anaesthetized dogs, hyperoxia has been shown to redistribute blood flow to the kidney, liver, and intestines, while blood flow to the myocardium, pancreas, and skeletal muscle decreases. 67 The amount of redistribution may vary at different P a O 2 s. Another explanation is recruitment of arteriovenous shunts, which provide relatively less resistance to flow than smaller arterioles/capillaries and therefore mitigate the increase in SVR. Shunting may also explain the decrease in VO 2 that is seen in some studies after oxygen administration. 17, 68 A bypass of metabolic active tissue will elevate venous PO 2 , reducing the arteriovenous oxygen difference used to calculate VO 2 . However, we did not take venous blood samples to calculate VO 2 , as this was beyond the scope of our study.
In our study, the majority of hyperoxia-induced changes became apparent above an oxygen tension of 20 kPa. From a hemodynamic and microcirculatory point of view, arterial oxygen tensions up to 20 kPa could therefore be suggested as "permissive hyperoxia." Interestingly, the range of 10-20 kPa is retrospectively associated with lower mortality in critically ill populations 5, 10 and with improved organ function after cardiac arrest. 9 Slight hyperoxia (up to a P a O 2 of 20 kPa) may thus be beneficial, because its influence on perfusion is possibly negligible.
However, even within this range, one prospective study in ICU patients
showed reduced mortality in a conservative oxygen group (median P a O 2 of 11.5 kPa) compared to a conventional oxygen group (median P a O 2 of 13.5 kPa). Beside some methodological issues, it should be noted that the study was stopped prematurely due to slow inclusion and was therefore underpowered for a mortality endpoint. 69, 70 Large randomized controlled studies in specific critically ill populations are required to determine whether slight hyperoxia is beneficial or not.
In healthy volunteers, supraphysiological arterial oxygen tensions, in the range of 14-73 kPa, have no effect on systemic DO 2 ; however, sublingual microcirculatory PVD decreased in a dose-dependent fashion. Simultaneous with the increase in C a O 2 , cardiac output decreased due to a decline in HR rather than stroke volume. SVRI increased slightly, while MAP remained unaltered. All hemodynamic changes appear negligible up to a P a O 2 of 20 kPa.
| Limitations
Our study has several limitations. For one, we used a noninvasive measurement of systemic hemodynamics which is less precise than the gold standard thermodilution method. The true effect size of hyperoxia on systemic hemodynamics may therefore be different.
Second, we included a relatively low number of participants, but the study was adequately powered given the prepost study design.
Third, we performed the study in a single-blind fashion due to the incremental oxygen exposure. This approach was chosen because of the possible residual effects of oxygen inhalation on hemodynamics for up to 30 minutes. 27 The risk of operator bias was reduced by blinded analysis of the microvascular recordings and the use of a set time-period for the averaging of hemodynamic variables.
Fourth, we did not include a control group that exclusively inhaled air during the study. This means we cannot exclude the possibility of time or comfort related changes in hemodynamics (eg, a reduction in HR due to increased comfort, rather than oxygen). However, we think it is highly unlikely that an increased level of comfort toward the end of the study is a factor in our results; all volunteers had ample time to adjust to the measurements before the start of the study and they showed no signs of anxiety at any time (eg, raised blood pressure). Our results on HR, MAP and stroke volume are in line with several other studies performed in healthy volunteers. 34, 35, 45, 49, 51, 71, 72 HR and sublingual microcirculatory perfusion decreased dose-dependently throughout the entire protocol; if there was no interaction with the intervention and the effect was solely due to increased comfort, we would have expected the effect to stabilize after an initial 20 or 30 minutes. Also, we are unaware of any mechanism that may link comfort with reduced sublingual perfusion. However, we cannot completely exclude a partial effect of comfort in our results; therefore, we advise future studies to include either a time control (eg, a group inhaling air only) or a phase with return to baseline (eg, air after oxygen exposure).
Fifth, the sublingual microcirculation may not be representative for other parts of the human body. However, we chose to investigate the sublingual area with SDF because of its noninvasive nature and has been used extensively in studies with the critically ill; it is a clinically relevant area as it is correlated with mortality and organ failure in patients with cardiogenic shock 73 and sepsis 74 and with postoperative complications after abdominal surgery. 75 Also, the sublingual area is perfused directly from the carotis externa, making it very closely related to the central circulation.
| PERSPECTIVE
Despite decades of research into the cardiovascular effects of hyperoxia, the effects of clinically relevant high arterial oxygen tensions (hyperoxia) on systemic DO 2 and sublingual microcirculatory perfusion are currently unknown.
In this arterial oxygen tension guided study, we found that in healthy volunteers, any level of normobaric oxygen supplementation has no effect on systemic DO 2 . Simultaneously, sublingual PVD was substantially decreased in the hyperoxic range of 20-73 kPa.
Due to the prevalence of hyperoxia in critically ill patients, these findings warrant studies to determine whether hyperoxia exacerbates pre-existing microcirculatory defects.
